Americans are seeing these medications everywhere, yet many users remain reluctant to disclose their own use
According to the FDA and Eli Lilly, you should not take Foundayo if you (1, 3): Have a personal or family history of medullary thyroid carcinoma Have Multiple Endocrine Neoplasia syndrome type 2 Are currently taking another GLP-1 receptor agonist medication Foundayo has not been studied in children (3)
The range of L-Carnitine supplements on the market is expanding along with its popularity
RxION has obtained signed releases from each patient featured
The gut microbiota composition influences neuroinflammation and brain function
It built on the success of earlier GLP-1s by engaging a second pathway, the Glucose-dependent Insulinotropic Polypeptide (GIP) receptor , leading to unprecedented weight loss results, often exceeding 20% of body weight